Searched for
ZITEN
Now, cut treatment cost by 80 per cent with new anti-diabetes drugThe economic burden of diabetes is high in India as most patients pay out-of-pocket, and due to lack of medical reimbursement.- New diabetes drug cuts cost by 80%A completely new drug in the 'gliptin' family has disrupted the anti-diabetes market by lowering the cost of therapy for patients by 80%.
- Drugmakers launch cut-price versions of type 2 diabetes medicineDozens of Indian drugmakers have launched cut-price versions of teneligliptin, a new generation medicine for type 2 diabetes patients.
- Cadila crashes the gliptin market with 'most affordable anti diabetic drug'Tenglyn, is a product belonging to a new class of drugs called gliptins, a segment that has witnessed the most aggressive growth among all ...
- Glenmark expecting USFDA nod for 4-6 products this fiscalGlenmark Pharmaceuticals is expecting approvals for four to six new products during the fiscal from the US Food and Drug Administration (US...
- New medicine could help diabetics save Rs 10,000 per yearA new anti-diabetes drug from the 'gliptin' family soon to be launched in India promises to lower treatment cost for patients by 55-60%.
Load More